CRIS Current Research Information System

SIRICO, MARIANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.102
NA - Nord America 516
EU - Europa 337
SA - Sud America 31
AF - Africa 25
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.014
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 487
CN - Cina 301
SG - Singapore 293
VN - Vietnam 192
IT - Italia 159
BD - Bangladesh 90
HK - Hong Kong 81
KR - Corea 60
FR - Francia 40
NL - Olanda 39
IN - India 28
DE - Germania 27
BR - Brasile 21
JP - Giappone 19
FI - Finlandia 18
CI - Costa d'Avorio 13
CA - Canada 12
MX - Messico 12
GB - Regno Unito 11
AT - Austria 8
ID - Indonesia 8
PL - Polonia 6
SC - Seychelles 6
CH - Svizzera 5
AR - Argentina 4
ES - Italia 4
PH - Filippine 4
RU - Federazione Russa 4
TH - Thailandia 4
BE - Belgio 3
IE - Irlanda 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
CO - Colombia 2
EG - Egitto 2
GH - Ghana 2
GR - Grecia 2
GT - Guatemala 2
IQ - Iraq 2
JO - Giordania 2
MY - Malesia 2
SA - Arabia Saudita 2
TW - Taiwan 2
UA - Ucraina 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CL - Cile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
MA - Marocco 1
NG - Nigeria 1
NP - Nepal 1
PK - Pakistan 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
RO - Romania 1
SE - Svezia 1
TR - Turchia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 2.014
Salva come PNG Salva come JPEG
Città #
Singapore 183
Hefei 152
San Jose 118
Hong Kong 73
Seoul 56
Dallas 53
Hanoi 49
Ho Chi Minh City 42
Council Bluffs 40
Ashburn 39
Los Angeles 31
Lauterbourg 25
New York 25
Amsterdam 24
Santa Clara 24
Milan 20
Beijing 19
Bologna 17
Bengaluru 16
Tokyo 16
Abidjan 13
Buffalo 13
Rome 13
Helsinki 10
Boardman 9
Haiphong 9
Lappeenranta 8
São Paulo 8
Mexico City 7
Chicago 6
Da Nang 6
Falkenstein 6
Jakarta 6
Frankfurt am Main 5
Guangzhou 5
Modena 5
Munich 5
Nuremberg 4
Quincy 4
Ravenna 4
Shanghai 4
Zurich 4
Bắc Giang 3
Castel Maggiore 3
Des Moines 3
Dublin 3
Huizhou 3
Monzuno 3
New Delhi 3
Ninh Bình 3
North Charleston 3
Phoenix 3
Reggio Emilia 3
Thái Nguyên 3
Venice 3
Vienna 3
Warsaw 3
Acalanes Ridge 2
Accra 2
Alghero 2
Amman 2
Bagnacavallo 2
Bozeman 2
Bắc Ninh 2
Camden 2
City of London 2
Cleveland 2
DeKalb 2
Düsseldorf 2
Genoa 2
Hải Dương 2
London 2
Montreal 2
Mumbai 2
Orem 2
Osaka 2
Ottawa 2
Palermo 2
Perugia 2
Qingdao 2
Quận Bình Thạnh 2
Roccalumera 2
San Francisco 2
Spinea 2
Tainan 2
Tashkent 2
Tongling 2
Toronto 2
Trani 2
Trevi 2
Turin 2
Tân Tiến 2
Wroclaw 2
Zhengzhou 2
Ân Thi 2
Afragola 1
Al Mansurah 1
Aliquippa 1
Almaty 1
Angeles City 1
Totale 1.302
Salva come PNG Salva come JPEG
Nome #
Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer 170
Oligometastatic breast cancer and metastasis-directed treatment: an aggressive multimodal approach to reach the cure 152
Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives 147
Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment 128
Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: biomarkers and beyond 121
Real-world effectiveness comparison of first-line palbociclib, ribociclib or abemaciclib plus endocrine therapy in advanced HR-positive/HER2-negative BC patients: results from the multicenter PALMARES-2 study 120
Locoregional treatment of de novo stage IV breast cancer in the era of modern oncology 120
Potential Impact of Preoperative Circulating Biomarkers on Individual Escalating/de-Escalating Strategies in Early Breast Cancer 115
Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy 97
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors 88
Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational study 78
Local treatment for oligoprogressive metastatic sites of breast cancer: efficacy, toxicities and future perspectives 75
An update on antibody–drug conjugates in urothelial carcinoma: state of the art strategies and what comes next 67
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study 59
Pharmacological Prevention in Breast Cancer: Current Evidence, Challenges, and Future Directions 56
Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review 56
ROLE OF HPV VACCINATION AFTER CARCINOMA IN SITU OF CERVIX UTERI (CIN) IN REAL-WORLD PATIENTS 53
Advances in anti-BRAF therapies for lung cancer 48
Hormonal Therapy For Endometriosis And The Risk Of Endometriosis-Associated Gynecologic Cancers: A Propensity Score-Adjusted Real-World Data Study 46
Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer 40
Canakinumab as treatment for COVID-19-related pneumonia: A prospective case-control study 37
ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment 36
Corrigendum to “Neoadjuvant endocrine therapy for luminal breast tumors: State of the art, challenges and future perspectives” [Crit. Rev. Oncol./Hematol. 181 (2023) 103900] (Critical Reviews in Oncology / Hematology (2023) 181, (S1040842822003249), (10.1016/j.critrevonc.2022.103900)) 33
Hallmarks of Appetite: A Comprehensive Review of Hunger, Appetite, Satiation, and Satiety 31
Cancer management during the COVID-19 world pandemic 30
Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study 29
Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: A literature-based meta-analysis of randomized trials 22
Corrigendum to “Navigating the complexity of PI3K/AKT pathway in HER-2 negative breast cancer: Biomarkers and beyond” [Crit. Rev. Oncol./Hematol. 200C (2024) 104404](S1040842824001471)(10.1016/j.critrevonc.2024.104404) 21
Totale 2.075
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.587
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.587
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202435 0 0 0 0 0 0 6 1 12 12 2 2
2024/2025285 10 23 19 25 20 18 9 19 1 17 38 86
2025/20261.755 68 127 237 147 121 60 242 94 276 124 203 56
Totale 2.075